Literature DB >> 11219953

[The use of therapeutic/prophylactic dragee "honey laminolact" in radiotherapy of uterine tumors].

I I Smirnova1, E I Filatova, A N Suvorov, E N Bylinskaia.   

Abstract

The study deals with the effect of a newly-developed food product--Honey Laminolact, containing live lactic acid bacteria, amino acids, trace elements, fruit pectine and immunomodulators-on the degree of response to radiation in 44 patients who received radiotherapy for uterine tumors. It was shown to lower response of the intestinal tract to radiation when the small pelvis was exposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11219953

Source DB:  PubMed          Journal:  Vopr Onkol        ISSN: 0507-3758


  3 in total

1.  Topical application of honey in the management of radiation mucositis: a preliminary study.

Authors:  Biswa Mohan Biswal; Ahmad Zakaria; Nik Min Ahmad
Journal:  Support Care Cancer       Date:  2003-02-19       Impact factor: 3.603

2.  Evaluating the effectiveness of topical application of natural honey and benzydamine hydrochloride in the management of radiation mucositis.

Authors:  Sadaksharam Jayachandran; Narasimhan Balaji
Journal:  Indian J Palliat Care       Date:  2012-09

Review 3.  Honey as a potential natural anticancer agent: a review of its mechanisms.

Authors:  Sarfraz Ahmed; Nor Hayati Othman
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-02       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.